![](/img/cover-not-exists.png)
Use of glatiramer acetate between 2010–2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients
Zecca, Chiara, Disanto, Giulio, Sacco, Rosaria, Riccitelli, Gianna C., Gobbi, ClaudioVolume:
19
Language:
english
Journal:
BMC Neurology
DOI:
10.1186/s12883-019-1383-6
Date:
December, 2019
File:
PDF, 789 KB
english, 2019